Viral Infections Associated with Anemia
Novelty in Biomedicine,
Vol. 13 No. 4 (2025),
28 October 2025
,
Page 240-253
https://doi.org/10.22037/nbm.v13i4.48404
Abstract
Background: Anemia is a serious blood disorder characterized by the bone marrow's inability to produce new blood cells, which can be either acquired or inherited. Exposure to viral infections can lead to anemia, including diseases caused by parvovirus B19, Epstein-Barr virus, cytomegalovirus, human immunodeficiency virus, hepatitis C virus, varicella-zoster virus, and SARS-CoV-2. While these infections are often subclinical in immunocompetent individuals, they can become critical and cause anemia in high-risk populations, such as immunocompromised individuals or those with underlying conditions like sickle cell disease, particularly in infants and pregnant women.
Materials and Methods: The search was performed using PubMed and Google Scholar for articles published from 2000 to 2024.The primary search string was: ("anemia" OR "erythroid aplasia") AND ("virus" OR "viral infection"), "Parvovirus B19", "Human Immunodeficiency Virus" OR "HIV", "Hepatitis C Virus" OR "HCV", "SARS-CoV-2" OR "COVID-19", "Varicella-Zoster Virus" OR "VZV", "Cytomegalovirus" OR "CMV", and "Epstein-Barr Virus" OR "EBV".
Results: Viral infections are important causes of anemia, through various mechanisms. Parvovirus B19 causes aplastic anemia by targeting red blood cell precursors, while HIV leads to anemia through chronic disease. Hepatitis C causes anemia via bone marrow suppression. SARS-CoV-2 disrupts iron metabolism through inflammation. Other viruses like CMV mainly cause anemia in immunocompromised patients.
Conclusion: This article aims to review the evidence regarding virus-induced anemia, detailing mechanisms such as erythroid progenitor cytotoxicity, chronic inflammation, and treatment-related haemolysis. Diagnostic strategies, ranging from serological assays to pathognomonic bone marrow findings, are discussed to assist laboratory science professionals and clinical specialists in diagnosing, treating, and managing patients with anemia.
- Viruses
- Anemia
- Immunocompromised
How to Cite
References
1. Fsky RA, Jones RJ. Aplastic anaemia. Lancet. 2005;365(9471):1647–56.
2. Alves ADR, Cubel Garcia RDCN, Cruz OG, Pinto MA, Amado Leon LA. Quantitative real-time PCR for differential diagnostics of parvovirus B19 infection in acute liver failure patients. Expert Rev Mol Diagn. 2019;19(3):259–66.
3. Morinet F, Leruez-Ville M, Pillet S, Fichelson S. Concise Review: Anemia Caused by Viruses. Stem Cells. 2011;29(11):1656–60.
4. Pascutti MF, Erkelens MN, Nolte MA. Impact of Viral Infections on Hematopoiesis: From Beneficial to Detrimental Effects on Bone Marrow Output. Front Immunol. 2016;7:364.
5. Marascio N, Rotundo S, Quirino A, Matera G, Liberto MC, Costa C, et al. Similarities, differences, and possible interactions between hepatitis E and hepatitis C viruses: Relevance for research and clinical practice. World J Gastroenterol. 2022;28(12):1226–38.
6. Chorba T, Coccia P, Holman RC, Tattersall P, Anderson LJ, Sudman J, et al. The Role of Parvovirus B19 in Aplastic Crisis and Erythema Infectiosum (Fifth Disease). J Infect Dis. 1986;154(3):383–93.
7. Florea AV, Ionescu DN, Melhem MF. Parvovirus B19 infection in the immunocompromised host. Arch Pathol Lab Med. 2007;131(5):799–804.
8. Boubaker K, Mahfoudhi M, Battikh A, Bounemra A, Maktouf C, Kheder A. Higher Endogenous Erythropoietin Levels in Hemodialysis Patients with Hepatitis C Virus Infection and Effect on Anemia. Open J Nephrol. 2015;5:29–34.
9. Allen EK, Penkert RR, Hankins JS, Surman SL, Van de Velde LA, Cotton A, et al. Immune Cell Profiles of Patients with Sickle Cell Disease during Parvovirus B19-Induced Transient Red Cell Aplasia. Vaccines (Basel). 2024;12(9):984.
10. Lamont RF, Sobel JD, Vaisbuch E, Kusanovic JP, Mazaki-Tovi S, Kim SK, et al. Parvovirus B19 infection in human pregnancy. BJOG. 2011;118(2):175–86.
11. Naides SJ, Howard EJ, Swack NS, True CA, Stapleton JT. Parvovirus B19 infection in human immunodeficiency virus type 1-infected persons failing or intolerant to zidovudine therapy. J Infect Dis. 1993;168(1):101–5. [
12. Čapenko S, Kozireva S, Folkmane I, Bernarde K, Rozentals R, Murovska M. Anemia as a complication of parvovirus B19 infection in renal transplant recipients. Medicina (Kaunas). 2012;48(6):299–304.
13. Murer L, Zacchello G, Bianchi D, Dall’Amico R, Montini G, Andreetta B, et al. Thrombotic microangiopathy associated with parvovirus B19 infection after renal transplantation. J Am Soc Nephrol. 2000;11(6):1132–7.
14. Giorgio E, De Oronzo MA, Iozza I, Di Natale A, Cianci S, Garofalo G, et al. Parvovirus B19 during pregnancy: a review. J Prenat Med. 2010;4(4):63–6.
15. Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575–82.
16. Mildvan D, Creagh T, Leitz G; Anemia Prevalence Study Group. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 HIV-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin. 2007;23(2):343–55.
17. Lombardi F, Quitadamo AL, Notarangelo LD, Pelizzoni A, Accorsi P, Olivetti F, et al. Varicella zoster virus-induced hemolytic crisis in an infant with severe vitamin B12 deficiency. J Pediatr Hematol Oncol. 2010;32(4):317–8.
18. Levy R, Weissman A, Blomberg G, Hagay ZJ. Infection by parvovirus B19 during pregnancy: a review. Obstet Gynecol Surv. 1997;52(4):254–9.
19. Shabani Z, Esghaei M, Keyvani H, Shabani F, Sarmadi F, Mollaie H, et al. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran. 2015;29:197.
20. Koduri PR. Novel cytomorphology of the giant proerythroblasts of parvovirus B19 infection. Am J Hematol. 1998;58(2):95–9
21. Ramezani A, Aghakhani A, Sharif MR, Banifazl M, Eslamifar A, Velayati AA. Anemia prevalence and related factors in HIV-infected patients: a cohort study. Iran J Pathol. 2008;3(3):125–8.
22. Helftenbein E, Kunz H, Hartter P. Labordiagnostik von Parvovirus-B19-Infektionen: Vergleich von zehn kommerziellen IgG- und IgM-Antikörpertests. Immun Infekt. 1994;22(5):181–6. German. [PMID: 7982714]
23. Muramatsu H, Kuriyama A, Anzai Y, et al. A co-infection of varicella-zoster virus and Pneumocystis jirovecii in a non-HIV immunocompromised patient: a case report. BMC Infect Dis. 2019;19:1092.
24. Gebremedhin KB, Haye TB. Factors associated with anemia among people living with HIV/AIDS taking ART in Ethiopia. Adv Hematol. 2019;2019:9614205.
25. Camacho J, Poveda F, Zamorano AF, Valencia ME, Vázquez JJ, Arnalich F. Serum erythropoietin levels in anaemic patients with advanced human immunodeficiency virus infection. Br J Haematol. 1992;82(3):608–14.
26. Sah S, Dahal P, Tamang G, Mandal D, Shah R, Pun S. Prevalence and predictors of anemia in HIV-infected persons in Nepal. HIV AIDS (Auckl). 2020;12.
27. Somia IK, Merati TP, Bakta IM, Putra Manuaba IB, Yasa WPS, Sukrama IDM, et al. High levels of serum IL-6 and serum hepcidin and low CD4 cell count were risk factors of anemia of chronic disease in HIV patients on combination antiretroviral therapy. HIV AIDS (Auckl). 2019;11:133–9.
28. ZainAlAbdin S, Aburuz S, Akour A, et al. Could anemia impact the severity of infections? COVID-19 as an example [version 2; peer review: 2 approved]. F1000Research. 2024;13:295.
29. Al-Anazi KA, Kanfar S, Aldayel A, Abduljalil O, Sayyed AH. Reversal of pure red cell aplasia by varicella zoster virus infection. J Hematol Clin Res. 2019;3:001–10.
30. Sah S, Dahal P, Tamang G, Mandal D, Shah R, Pun S. Prevalence and predictors of anemia in HIV-infected persons in Nepal. HIV AIDS (Auckl). 2020;12.
31. Nouri M, Kamakifar P, Khodabandehlou N, Sadri Nahand J, Tavakoli A, Norooznezhad F, et al. … Med J Islam Repub Iran. 2019;33:137.
32. Ong JP, Younossi ZM. Managing the hematologic side effects of antiviral therapy for chronic hepatitis C: anemia, neutropenia, and thrombocytopenia. Cleve Clin J Med. 2004;71 Suppl 3:S17–21.
33. Brown KE. Haematological consequences of parvovirus B19 infection. Baillieres Best Pract Res Clin Haematol. 2000;13(2):245–59.
34. Aka N, As M, Ah A, Gam AA. Correlation between liver function tests and polymerase chain reaction in chronic hepatitis C patients. … 2015.
35. Gürsoy V, Avcı S, Ermurat S, Erol A, Yazıcı M. Anemia and COVID-19. Eur Res J. 2023;9(5):1074–82.
36. An C, Oh HC, Chang JH, et al. Early triage of patients diagnosed with COVID-19 based on predicted prognosis: a Korean national cohort study. Res Sq. 2020.
37. Spivak JL, Barnes DC, Fuchs E, Quinn TC. Serum immunoreactive erythropoietin in HIV-infected patients. JAMA. 1989;261(21):3104–7. Also included in this entry as provided: Horsburgh CR. Mycobacterium avium complex infection in the acquired immunodeficiency syndrome. N Engl J Med. 1991;324:1332.
38. Lippi G, Salvagno G, Pegoraro M, Militello V, Caloi C, Peretti A, et al. Assessment of immune response to SARS-CoV-2 with fully automated MAGLUMI 2019-nCoV IgG and IgM chemiluminescence immunoassays. Clin Chem Lab Med. 2020;58(7):1156–9.
39. Meidani M, Rezaei F, Maracy MR, Avijgan M, Tayeri K. Prevalence, severity, and related factors of anemia in HIV/AIDS patients. J Res Med Sci. 2012;17(2):138–42. [Link: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525030/]
40. Chen CC, Chen CS, Wang WY, Ma JS, Shu HF, Fan FS. Parvovirus B19 infection presenting with severe erythroid aplastic crisis during pregnancy in a woman with autoimmune hemolytic anemia and alpha-thalassemia trait: a case report. J Med Case Rep. 2015;9:58. [DOI: https://doi.org/10.1186/s13256-015-0542-7]
41. Shabani Z, Esghaei M, Keyvani H, Shabani F, Sarmadi F, Mollaie H, et al. Relation between parvovirus B19 infection and fetal mortality and spontaneous abortion. Med J Islam Repub Iran. 2015;29:197.
42. Hasan Y, Brown K. Viral eradication restores normal iron status in chronic hepatitis C patients with abnormal iron studies. Ann Hepatol. 2020;19(4):422–6.
43. Mahmood KA, Siddiqi H, Sajjad A, Shoukat S, Mehmood Z, Wasim A, et al. Iron-deficiency anemia: a study of risk factors among adult population of Quetta Valley. Health (NY). 2012;4:607–11.
44. Beader N, Kolarić B, Slačanac D, Tabain I, Vilibić-Čavlek T. Seroepidemiological study of Epstein–Barr virus in different population groups in Croatia. Isr Med Assoc J. 2018;20(2):86–90.
45. Sulkowski MS. Anemia in the treatment of hepatitis C virus infection. Clin Infect Dis. 2003;37(Suppl 4):S315–22.
46. Giridhar K, Sawhney R, Chichula D, Shet A. Serum hepcidin detects iron deficiency anemia in HIV infected patients with anemia of inflammation. Blood. 2015.
47. De Santis GC, Brunetta DM, Vilar FC, Brandão RA, de Albernaz Muniz RZ, de Lima GM, et al. Hematological abnormalities in HIV-infected patients. Int J Infect Dis. 2011;15(12):e808–11.
48. De Las Cuevas Allende R, Díaz de Entresotos L, Conde Díez S. Anaemia of chronic diseases: pathophysiology, diagnosis and treatment. Med Clin (Barc). 2021;156(5):235–42.
49. Rauff B, Idrees M, Shah SA, Butt S, Butt AM, Ali L, et al. Hepatitis associated aplastic anemia: a review. Virol J. 2011;8:87.
50. Moriishi K, Matsuura Y. Mechanisms of hepatitis C virus infection. Antivir Chem Chemother. 2003;14(6):285–97.
51. Sullivan PS, Hanson DL, Chu SY, Jones JL, Ward JW. Epidemiology of anemia in HIV-infected persons: results from the multistate adult and adolescent spectrum of HIV disease surveillance project. Blood. 1998;91(1):301–8.
52. Abraham AG, Palella FJ, Li X, Estrella MM, Kingsley LA, Witt MD, et al. The impact of impaired kidney function and HIV infection on the risk of anemia. AIDS Res Hum Retroviruses. 2012;28(12):1666–71.
53. Duque X, Mendoza E, Morán S, Suárez-Arriaga MC, Morales-Sánchez A, Fontes-Lemus JI, et al. Epstein–Barr virus infection is associated with elevated hepcidin levels. Int J Mol Sci. 2023;24(2):1630.
54. Majumdar S, Bean CJ, De Staercke C, Bost J, Nickel R, Coates T, et al. Parvovirus B19 infection in sickle cell disease: an analysis from the Centers for Disease Control haemoglobinopathy blood surveillance project. Transfus Med. 2020;30(3):226–30.
55. Saif MW. HIV-associated autoimmune hemolytic anemia: an update. AIDS Patient Care STDS. 2001;15(4):217–24.
56. Mishra B, Malhotra P, Ratho RK, Singh MP, Varma S, Varma N. Human parvovirus B19 in patients with aplastic anemia. Am J Hematol. 2005;79(2):166–7.
57. Bergamaschi G, Borrelli de Andreis F, Aronico N, et al. Anemia in patients with COVID-19: pathogenesis and clinical significance. Clin Exp Med. 2021;21(2):247.
58. Landry ML. Parvovirus B19. Microbiol Spectr. 2016;4(3):DMIH2-0008-2015.
59. Kakavandi S, Hajikhani B, Azizi P, Aziziyan F, Nabi-Afjadi M, Farani MR, et al. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal. 2024;22(1):126.
60. Wiegering V, Schick J, Beer M, et al. Varicella-zoster virus infections in immunocompromised patients: a single-centre 6-years analysis. BMC Pediatr. 2011;11:31.
61. Aryastuti SA, Dewi SR, Masyeni S. High prevalence of anemia among HIV-infected patients: a cross-sectional study in Bali-Indonesia. Biomed Pharmacol J. 2021;14(1).
62. Butler LM, Dzabic M, Bakker F, Davoudi B, Jeffery H, Religa P, et al. Human cytomegalovirus inhibits erythropoietin production. J Am Soc Nephrol. 2014;25(8):1669–78.
63. Amer K, Mona R, Khaled M, AlKhazindar T, Elsayed D. Screening for viral infection and anemia among pregnant women with bad pregnancy outcome in Egyptian population. 2016;2(11):700–6.
64. Tun MM, Chowdhury T, Nway N, Noel P, Gousy N, Roy A, et al. Parvovirus infection leading to severe anemia in an adult patient with HIV disease. Cureus. 2022;14.
65. Haklar G. Liver function tests in chronic viral hepatitis cases. Marmara Med J. 2016;29(2):6–9.
66. Bain BJ. Pathogenesis and pathophysiology of anemia in HIV infection. Curr Opin Hematol. 1999;6(2):89–93.
67. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–62.
68. Kotwal J, Singh V, Kotwal A, Dutta V, Nair V. Haematological and bone marrow changes in symptomatic HIV infection with special mention of functional iron deficiency, anaemia of critically ill and haemophagocytic lymphohistiocytosis. Med J Armed Forces India. 2013;69(4):319–25.
69. Mobin A, Manzoor I, Shaikh H, Ebrahim MA. Chronic liver disease. Prof Med J. 2018;25:292–6.
70. Krishnan SM, Dixit NM. Ribavirin-induced anemia in hepatitis C virus patients undergoing combination therapy. PLoS Comput Biol. 2011;7(2):e1001072.
71. Taisescu CI, Demetrian A, Biciusca V, Dricu A, Artene SA, Cioc C, et al. Ribavirin-induced anemia in patients with chronic hepatitis C virus infection. Rev Chim (Bucharest). 2018;69(12):3648–52.
72. Mitrani R, Gollomp K, Lambert MP, Obstfeld A. The immature reticulocyte fraction as an aid in the diagnosis and prognosis of parvovirus B19 infection in sickle cell disease. Blood. 2018;132(Suppl 1):3678.
73. Natov SN, Pereira BJ. Hepatitis C virus in chronic dialysis patients. Minerva Urol Nefrol. 2005;57(3):175–97.
74. Nabi S, Kahlon P, Goggins M, Patel A. VZV encephalitis following successful treatment of CMV infection in a kidney transplant patient. BMJ Case Rep. 2014;2014:bcr2014206655.
75. Gupta V, Pratap R, Kumar A, Saini I, Shukla J. Epidemiological features of aplastic anemia in Indian children. Indian J Pediatr. 2013.
76. Obeagu EI, Obeagu GU, Ukibe NR, Oyebadejo SA. Anemia, iron, and HIV: decoding the interconnected pathways: a review. Medicine (Baltimore). 2024;103(2):e36937.
77. Kebede SS, Yalew A, Yesuf T, Melku M, Bambo GM, Woldu B. Immune hemolytic anemia among HIV-infected adults: magnitude and associated factors, University of Gondar Hospital, 2021—cross-sectional study. PLoS One. 2022;17(10):e0274464.
78. Pertiwi D, Sofro MA, Winarni TI, Probandari A. Duration of zidovudine consumption correlates with anemia in people living with HIV. J Pharm Sci Community. 2023.
79. Poudel A, Pariyar R, Karki H, Giri A, Bhusal S, Poudel R, et al. Prevalence of anemia and mortality among anemic patients with COVID-19 in a tertiary care setting in Nepal. J Patan Acad Health Sci. 2023;10:72–8.
80. Kakavandi S, Hajikhani B, Azizi P, Aziziyan F, Nabi-Afjadi M, Farani MR, et al. COVID-19 in patients with anemia and haematological malignancies: risk factors, clinical guidelines, and emerging therapeutic approaches. Cell Commun Signal. 2024;22(1):126.
81. Kumar KJ, Kumar HC, Manjunath VG, Arun V. Autoimmune hemolytic anemia due to varicella infection. Iran J Pediatr. 2013;23(4):491–2.
82. Espy MJ, Teo R, Ross TK, Svien KA, Wold AD, Uhl JR, et al. Diagnosis of varicella-zoster virus infections in the clinical laboratory by LightCycler PCR. J Clin Microbiol. 2000;38(9):3187–9.
83. Djoerban Z. Viral load profiles in drug users with asymptomatic HIV infection and normal CD4 cell counts. Med J Indones. 2002;11(3):143.
84. Servey JT, Reamy BV, Hodge J. Clinical presentations of parvovirus B19 infection. Am Fam Physician. 2007;75(3):373–6.
85. Duque X, Mendoza E, Morán S, Suárez-Arriaga MC, Morales-Sánchez A, Fontes-Lemus JI, et al. Epstein–Barr virus infection is associated with elevated hepcidin levels. Int J Mol Sci. 2023;24(2):1630.
86. Ferrari de Freitas L, de Melo Silva J, Nogueira Barbosa A, Miranda Santos E, Pinheiro-Silva R, Soares Pontes G. Epidemiological and liver biomarkers profile of Epstein–Barr virus infection and its coinfection with cytomegalovirus in patients with hematological diseases. Biomolecules. 2021;11(8):1151.
87. Henry B, de Oliveira M, Benoit S, Plebani M, Lippi G. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in COVID-19: a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–8.
88. Lai JL, Chen YH, Liu YM, Yuan JJ, Lin J, Huang AQ, et al. Prevalence and risk factors of anaemia in hospitalised HIV-infected patients in southeast China: a retrospective study. Epidemiol Infect. 2019;147:e81.
89. Shkodrani E, Frangaj S, Cenko A, Xhaja A. Chronic HCV infection with cryoglobulinemia associated with cutaneous subacute lupus. 2018.
90. Saigal S, Singh RK, Kapoor G, Baronia A. Varicella zoster virus vasculopathy in adult: a rare case report. J Clin Case Rep. 2012.
91. Slavov SN, Kashima S, Wagatsuma VM, et al. Glycoprotein B genotyping of human cytomegalovirus strains isolated from Brazilian patients with sickle cell disease and beta thalassemia major. Viral Immunol. 2015;28(2):123–9.
92. de Matos SB, Meyer R, Lima FWM. Seroprevalence and serum profile of cytomegalovirus infection among patients with hematologic disorders in Bahia State, Brazil. J Med Virol. 2011;83(2):298–304.
93. Claster S. Biology of anemia, differential diagnosis, and treatment options in human immunodeficiency virus infection. J Infect Dis. 2002;185(Suppl 2):S105–9.
94. Meloni DF, Faré PB, Milani GP, Lava SAG, Bianchetti MG, Renzi S, et al. Hemolytic anemia linked to Epstein–Barr virus infectious mononucleosis: a systematic review. J Clin Med. 2025;14(4):1283.
95. Suii H, Ozeki I, Tatsumi R, Yamaguchi M, Kimura M, Arakawa T, et al. Safety of sofosbuvir and ribavirin combination therapy in a patient who developed anemia due to ribavirin. Case Rep Hepatol. 2017;2017:8793895.
96. Tao Z, Xu J, Chen W, et al. Anemia is associated with severe illness in COVID-19: a retrospective cohort study. J Med Virol. 2021;93(3):1478–88.
97. Taştemur M, Arık G, Heybeli H, Selvi Öztorun H, Sılay K, Ateş I, et al. The relationship between anemia and mortality in elderly COVID-19 patients. Cumhuriyet Med J. 2022.
98. Mayer A, Podlech J, Kurz S, Steffens HP, Maiberger S, Thalmeier K, et al. Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes. J Virol. 1997;71(6):4589–98.
99. Natov SN, Pereira BJ. Hepatitis C virus in chronic dialysis patients. Minerva Urol Nefrol. 2005;57(3):175–97.
100. Wang J, Yang Z, Ren D, Shi Z, Fang K, Li Z. Disseminated varicella-zoster virus infection in an aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome patient: a case report. Front Cell Infect Microbiol. 2023;13:1163872.
101. Mildvan D, Creagh T, Leitz G; Anemia Prevalence Study Group. Prevalence of anemia and correlation with biomarkers and specific antiretroviral regimens in 9690 HIV-infected patients: findings of the Anemia Prevalence Study. Curr Med Res Opin. 2007;23(2):343–55.
102. Yip CC, Sridhar S, Leung K, Cheng AK, Chan K, Chan JF, et al. Evaluation of RealStar® Alpha Herpesvirus PCR Kit for detection of HSV-1, HSV-2, and VZV in clinical specimens. Biomed Res Int. 2019;2019:5715180.
103. Shedid M, Abdelmonem M, Boraik A, Elmetwalli A, Hassan D. Hematological parameters throughout the first month of direct-acting antivirals plus ribavirin for HCV. Am J Clin Pathol. 2019.
104. Elnaggar MZ, Bichari W, Elshinnawy H. Effect of HCV infection versus HBV infection on the response to erythropoietin therapy in the treatment of anemia in prevalent haemodialysis patients. Egypt J Hosp Med. 2018;70(1):92–6.
105. Zauli G, Re MC, Visani G, Furlini G, Mazza P, Vignoli M, et al. Evidence for an HIV-1-mediated suppression of uninfected hematopoietic (CD34+) cells in AIDS patients. J Infect Dis. 1992;166(4):710–6.
- Abstract Viewed: 658 times
- pdf Downloaded: 123 times